Results 241 to 250 of about 2,218,427 (310)
Generation and characterisation of a humanised GLP-1 receptor mouse model for translational drug development. [PDF]
Sonne N +15 more
europepmc +1 more source
This study investigated a novel WST‐8‐based assay for evaluating d‐Amino acid oxidase (DAO) inhibitors. We confirmed its effectiveness using known inhibitors and found that uremic toxins possess relatively weak inhibitory activity compared to existing drugs.
Kahoko Miyake +4 more
wiley +1 more source
Correction: Anticancer drug development against ribosome synthesis and the nucleolus. [PDF]
Loiacono A, Huang S.
europepmc +1 more source
This protocol paper outlines methods to establish the success of a time‐resolved serial crystallographic experiment, by means of statistical analysis of timepoint data in reciprocal space and models in real space. We show how to amplify the signal from excited states to visualise structural changes in successful experiments.
Jake Hill +4 more
wiley +1 more source
Genetic Variations in the P2X7 Receptor: Opportunities and Challenges for Drug Development. [PDF]
Cheah JSY +3 more
europepmc +1 more source
Bisphenol A (BPA), a common chemical in plastics, exerts dual effects on bladder cancer cells: low doses promote growth and migration, while high doses suppress growth and migration. Multi‐omics and bioinformatics reveal BPA acts via MAPK and inflammatory pathways.
Shaomin Niu +10 more
wiley +1 more source
Genetic evidence informs the direction of therapeutic modulation in drug development. [PDF]
Chen R +10 more
europepmc +1 more source
Harnessing Organoid Platforms for Nanoparticle Drug Development. [PDF]
Chen L +5 more
europepmc +1 more source

